Search Results - "MACON, W. R"

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas by Feldman, A L, Law, M, Remstein, E D, Macon, W R, Erickson, L A, Grogg, K L, Kurtin, P J, Dogan, A

“…Oncogenes involved in recurrent chromosomal translocations serve as diagnostic markers and therapeutic targets in hematopoietic tumors. In contrast to myeloid…”
Get full text

Bowel perforation in intestinal lymphoma: incidence and clinical features by Vaidya, R., Habermann, T.M., Donohue, J.H., Ristow, K.M., Maurer, M.J., Macon, W.R., Colgan, J.P., Inwards, D.J., Ansell, S.M., Porrata, L.F., Micallef, I.N., Johnston, P.B., Markovic, S.N., Thompson, C.A., Nowakowski, G.S., Witzig, T.E.

“…Perforation is a serious life-threatening complication of lymphomas involving the gastrointestinal (GI) tract. Although some perforations occur as the initial…”
Get full text

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study by Nowakowski, G S, LaPlant, B, Habermann, T M, Rivera, C E, Macon, W R, Inwards, D J, Micallef, I N, Johnston, P B, Porrata, L F, Ansell, S M, Klebig, R R, Reeder, C B, Witzig, T E

“…Lenalidomide was shown to have significant single-agent activity in relapsed aggressive non-Hodgkin's lymphoma (NHL). We conducted a phase I trial to establish…”
Get full text

Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas by Feldman, A L, Sun, D X, Law, M E, Novak, A J, Attygalle, A D, Thorland, E C, Fink, S R, Vrana, J A, Caron, B L, Morice, W G, Remstein, E D, Grogg, K L, Kurtin, P J, Macon, W R, Dogan, A

“…Peripheral T-cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK) inhibition, are needed…”
Get full text

Post‐Transplant Lymphoproliferative Disorders Following Liver Transplantation: Incidence, Risk Factors and Survival by Kremers, W. K., Devarbhavi, H. C., Wiesner, R. H., Krom, R. A. F., Macon, W. R., Habermann, T. M.

“…This study investigates retrospectively the incidence, risk factors and mortality of post‐transplant lymphoproliferative disorders (PTLD) in adult orthotopic…”
Get full text

Subcutaneous panniculitis-like T-cell lymphoma : Clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes by SALHANY, K. E, MACON, W. R, SWERDLOW, S. H, CHOI, J. K, ELENITSAS, R, LESSIN, S. R, FELGAR, R. E, WILSON, D. M, PRZYBYLSKI, G. K, LISTER, J, WASIK, M. A

“…Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is an uncommon cutaneous lymphoma that has been proposed as a distinct clinicopathologic entity, but…”
Get full text

TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation by Felgar, RE, Macon, WR, Kinney, MC, Roberts, S, Pasha, T, Salhany, KE

“…TIA-I is a 15-kd cytotoxic granule-associated protein expressed in natural killer (NK) cells and cytotoxic T lymphocytes. TIA-1 expression was evaluated by…”
Get full text

NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis by Morice, W G, Macon, W R, Dogan, A, Hanson, C A, Kurtin, P J

Get full text

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials by Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, Giovannino, Habermann, T. M., Witzig, T. E., Vitolo, U., Nowakowski, G. S.

“…Lenalidomide-RCHOP (R2-CHOP21) has been shown to be safe and effective in patients with untreated diffuse large B-cell lymphoma (DLBCL). The aim of this…”
Get full text

Natural Killer-Like T-Cell Lymphomas: Aggressive Lymphomas of T-Large Granular Lymphocytes by Macon, William R., Williams, Michael E., Greer, John P., Hammer, Richard D., Glick, Alan D., Collins, Robert D., Cousar, John B.

“…Natural killer (NK)-like T cells are major histocompatibility complex-unrestricted cytotoxic T cells that are surface CD3-positive, express NK-cell antigens,…”
Get full text

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas by Briski, R, Feldman, A L, Bailey, N G, Lim, M S, Ristow, K, Habermann, T M, Macon, W R, Inwards, D J, Colgan, J P, Nowakowski, G S, Kaminski, M S, Witzig, T E, Ansell, S M, Wilcox, R A

“…Peripheral T-cell lymphomas (PTCLs) are a heterogenous group of aggressive non-Hodgkin’s lymphomas that are incurable in the majority of patients with current…”
Get full text

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma by Tracy, S I, Maurer, M J, Witzig, T E, Drake, M T, Ansell, S M, Nowakowski, G S, Thompson, C A, Inwards, D J, Johnston, P B, Micallef, I N, Allmer, C, Macon, W R, Weiner, G J, Slager, S L, Habermann, T M, Link, B K, Cerhan, J R

“…We evaluated whether vitamin D insufficiency (VDI; 25(OH)D <20 ng/ml) was associated with adverse outcomes among follicular lymphoma (FL) patients using an…”
Get full text

The expression of TIA-1 + cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30 + anaplastic large cell lymphomas (ALCL): Correlation with morphology, immunophenotype, ultrastructure, and clinical features by Felgar, Raymond E, Salhany, Kevin E, Macon, William R, Pietra, Giuseppe G, Kinney, Marsha C

“…Anaplastic large cell lymphomas (ALCL) are a heterogeneous group of CD30 + large cell lymphomas; the most characteristic type have a T or null cell phenotype,…”
Get full text

T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients by Greer, J P, Macon, W R, Lamar, R E, Wolff, S N, Stein, R S, Flexner, J M, Collins, R D, Cousar, J B

“…Clinicopathologic features of 44 patients with well-documented T-cell-rich B-cell lymphomas (TCRBCLs) were reviewed to determine if there were distinguishing…”
Get more information

T-Cell-Rich Large-B-Cell Lymphomas Contain Non-Activated CD8 + Cytolytic T Cells, Show Increased Tumor Cell Apoptosis, and Have Lower Bcl-2 Expression Than Diffuse Large-B-Cell Lymphomas by Felgar, Raymond E., Steward, Katherine R., Cousar, John B., Macon, William R.

“…The factor(s) responsible for the reduced B cell number and increased T cell infiltrate in T-cell-rich large-B-cell lymphomas (TCRBCLs) have not been well…”
Get full text

Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma by STEIN, R. S, GREER, J. P, GOODMAN, S, BRANDT, S. J, MORGAN, D. S, MACON, W. R, MCCURLEY, T. L, WOLFF, S. N

“…Between September 1986 and June 1998, 99 patients with relapsed or refractory IGL received intensified preparative therapy and underwent autologous…”
Get full text

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma by Porrata, L F, Ristow, K M, Habermann, T M, Macon, W R, Witzig, T E, Colgan, J P, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Nowakowski, G, Thompson, C A, Markovic, S N

“…The peripheral blood absolute lymphocyte/monocyte count ratio at diagnosis (ALC/AMC-DX) predicts survival in classical Hodgkin lymphoma (cHL). However, a…”
Get full text

T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry by MACON, W. R, SALHANY, K. E

“…Peripheral T-cell lymphomas (PTCLs) are often diagnosed after demonstration of T-lineage-related antigen expression on neoplastic lymphocytes by paraffin…”
Get full text

Paracortical nodular T-cell lymphoma. Identification of an unusual variant of peripheral T-cell lymphoma by Macon, W R, Williams, M E, Greer, J P, Cousar, J B

“…Peripheral T-cell lymphomas (PTCLs) are regarded as diffuse proliferations. We describe an unusual paracortical nodular growth pattern in four nodal PTCLs that…”
Get more information

Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: Are they two different diseases? by GHOBRIAL, Irene M, HABERTNANN, Thomas M, MACON, William R, RISTOW, Kay M, LARSON, Timothy S, WALKER, Randall C, ANSELL, Stephen M, GORES, Gregory J, STEGALL, Mark D, MCGREGOR, Christopher G

“…The objective of the authors' study was to characterize the clinical and pathologic differences between patients who develop posttransplant lymphoproliferative…”
Get full text